Found: 32
Select item for more details and to access through your institution.
Federal Trade Commission Oversight of the Pharmaceutical Industry.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
The Constitutionality of Medicare Drug-Price Negotiation under the Takings Clause.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, n. 4, p. 961, doi. 10.1017/jme.2024.10
- By:
- Publication type:
- Article
The Political Economy of Market Power in Pharmaceuticals.
- Published in:
- Journal of Health Politics, Policy & Law, 2023, v. 48, n. 2, p. 215, doi. 10.1215/03616878-10234184
- By:
- Publication type:
- Article
HOW LAW MADE NEOLIBERALISM.
- Published in:
- Boston Review, 2022, v. 47, n. 2, p. 86
- By:
- Publication type:
- Article
The Public History of Trade Secrets.
- Published in:
- U.C. Davis Law Review, 2022, v. 55, n. 3, p. 1367
- By:
- Publication type:
- Article
SHOULD THE U.S. GOVERNMENT ACTIVELY ASSERT ITS OWN PATENTS?
- Published in:
- Journal of Intellectual Property & Entertainment Law, 2021, v. 11, n. 1, p. 19
- By:
- Publication type:
- Article
Transparency of Regulatory Data across the European Medicines Agency, Health Canada, and US Food and Drug Administration.
- Published in:
- Journal of Law, Medicine & Ethics, 2021, v. 49, n. 3, p. 456, doi. 10.1017/jme.2021.67
- By:
- Publication type:
- Article
Addressing the Risks That Trade Secret Protections Pose for Health and Rights.
- Published in:
- Health & Human Rights: An International Journal, 2021, v. 23, n. 1, p. 129
- By:
- Publication type:
- Article
Realizing Public Rights Through Government Patent Use.
- Published in:
- Journal of Law, Medicine & Ethics, 2021, v. 49, n. 1, p. 34, doi. 10.1017/jme.2021.7
- By:
- Publication type:
- Article
THE NEW POLITICS OF CARE.
- Published in:
- Boston Review, 2020, v. 45, n. 3, p. 11
- By:
- Publication type:
- Article
Building a Law-and-Political-Economy Framework: Beyond the Twentieth-Century Synthesis.
- Published in:
- Yale Law Journal, 2020, v. 129, n. 6, p. 1784
- By:
- Publication type:
- Article
The Law of Informational Capitalism.
- Published in:
- 2020
- By:
- Publication type:
- Book Review
Confidentiality Orders and Public Interest in Drug and Medical Device Litigation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
FREE SPEECH, INCO RPO RATED.
- Published in:
- Boston Review, 2019, v. 44, n. 3, p. 156
- By:
- Publication type:
- Article
The Right to Medicines in an Age of Neoliberalism.
- Published in:
- Humanity: An International Journal of Human Rights, Humanitarianism & Development, 2019, v. 10, n. 1, p. 79, doi. 10.1353/hum.2019.0003
- By:
- Publication type:
- Article
Dangerous Times: The FDA's Role in Information Production, Past and Future.
- Published in:
- Minnesota Law Review, 2018, v. 102, n. 6, p. 2357
- By:
- Publication type:
- Article
Legal Challenges to State Drug Pricing Laws.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Trial Transparency: The FDA Should and Can Do More.
- Published in:
- Journal of Law, Medicine & Ethics, 2017, v. 45, p. 33, doi. 10.1177/1073110517750618
- By:
- Publication type:
- Article
ORDER WITHOUT INTELLECTUAL PROPERTY LAW: OPEN SCIENCE IN INFLUENZA.
- Published in:
- Cornell Law Review, 2017, v. 102, n. 6, p. 1539
- By:
- Publication type:
- Article
Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Free Speech and Pharmaceutical Regulation -- Fishy Business.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Innovation Sticks: The Limited Case for Penalizing Failures to Innovate.
- Published in:
- University of Chicago Law Review, 2015, v. 82, n. 4, p. 1781
- By:
- Publication type:
- Article
INTELLECTUAL PROPERTY'S LEVIATHAN.
- Published in:
- Law & Contemporary Problems, 2014, v. 77, n. 4, p. 131
- By:
- Publication type:
- Article
The Continuum of Excludability and the Limits of Patents.
- Published in:
- 2013
- By:
- Publication type:
- Essay
Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of "Secondary" Pharmaceutical Patents.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0049470
- By:
- Publication type:
- Article
The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism.
- Published in:
- UCLA Law Review, 2012, v. 59, n. 4, p. 970
- By:
- Publication type:
- Article
Harmonization and Its Discontents: A Case Study of TRIPS Implementation in India's Pharmaceutical Sector.
- Published in:
- California Law Review, 2009, v. 97, n. 6, p. 1571
- By:
- Publication type:
- Article
Commentary: Innovation Policy for a New Era.
- Published in:
- Journal of Law, Medicine & Ethics, 2009, v. 37, n. 2, p. 264, doi. 10.1111/j.1748-720X.2009.00370.x
- By:
- Publication type:
- Article
Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
The Access to Knowledge Mobilization and the New Politics of Intellectual Property.
- Published in:
- Yale Law Journal, 2008, v. 117, n. 5, p. 804, doi. 10.2307/20455812
- By:
- Publication type:
- Article
ADDRESSING GLOBAL HEALTH INEQUITIES: AN OPEN LICENSING APPROACH FOR UNIVERSITY INNOVATIONS.
- Published in:
- Berkeley Technology Law Journal, 2005, v. 20, n. 2, p. 1031
- By:
- Publication type:
- Article